Advancing cellular immunotherapy to treat cancer Pioneering stem cell research & therapy
Turning gamma delta (γδ) T cells
and natural killer (NK) cells into
“off-the-shelf” immunotherapeutics
for various cancers.
Note: The background image shows iPSC-derived NK cells and the video shows iPSC-derived γδ T cells killing colorectal cancer cells.